Patent AnalyticsExaminers
Rankings

Company or institution

Kala Pharmaceuticals, Inc.

61 applicationsfiled 2007 to 2022

Allowance rate
82%
+7 pts vs the USPTO range 71% to 90%
Rejections before allowance
1.1
−0.5 vs the USPTO
Months to first action
7.3 mo
−11.3 vs the USPTO
Needed an RCE
13%
−14 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds40 apps
A61K Medical preparations21 apps

Art units

162431 apps
162513 apps
16153 apps
16263 apps
16223 apps
16572 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
17747754THERAPEUTIC COMPOUNDS AND USES THEREOF2022-05-18Abandoned0012.6 mo
17554375CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF2021-12-17Abandoned1017.5 mo
17389000CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF2021-07-29Abandoned00n/a
15702975Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15163454Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15174827Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15572480Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15671146Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15396844Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15832656Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 61 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in